Our patches offer non-invasive drug delivery directly through the skin. Whether for systemic or localized treatment, these patches provide continuous, patient-friendly solutions for maintaining therapeutic control.
Our transdermal patches deliver consistent medication levels into the bloodstream, ensuring steady therapeutic effects over time with minimal dosing.
Topical patches are perfect for targeted, localized treatment, applying medication directly where it’s needed without affecting the rest of the body.
Our patented MicroDEP technology uses tiny drug deposits on oral thin films to accelerate delivery.
This first-of-its-kind innovation—approved by the FDA— allows for ultra-precise dosing, providing as little as five micrograms for fast, reliable absorption.
ARx supports every stage of the drug delivery lifecycle. From formulation to manufacturing, we expedite timelines and improve patient outcomes with an eye for optimizing safety and effectiveness.
Process Development
We accelerate filing and commercialization processes with scalable manufacturing. Using QbD principles, we optimize production with yields and regulatory approval in mind.
Commercial Manufacturing
ARx produces over 100 million units annually in FDA-registered cGMP facilities. We guarantee a reliable supply of high-quality films and patches from launch through production.
Quality Management
Quality comes first. At ARx, we prioritize transparency and QC, ensuring compliance at each stage in your development process.
Analytical Testing
Every ARx product is driven by advancing patient health. We thoroughly test formulations on-site to ensure they meet product specifications and the highest clinical standards.
Product Development
ARx is driven by collaboration. We work hand-in-hand with partners to design, develop and bring life-changing products to market and fulfill subsequent demand.
Have questions about your delivery options?
Talk to one of our experts about your product and development needs.